November 16 -17, 2020
Tokyo, Japan
Following on from the achievement of the 8th International Conference on Parkinsons and Movement Disorders in June 2020 at Vienna, Austria, we are amazingly pleased to declare, 9th International Conference on Parkinsons and Movement Disorders at Tokyo, Japan during November 16-17, 2020.
The primary focal point of the Parkinsons Congress 2020 is to improve the remedies for Parkinsons disease, quicken the interpretation of front line disclosure at the clinical level, and further advance worldwide logical collaboration, discussion and trade.
Embracing a profoundly multidisciplinary approach, Parkinsons Congress 2020 will mean to draw participation of neurologists, neuroscientists, researchers, sharing the shared objective of propelling the administration, treatment, and care.
Through a series of entire sessions, workshops and exhibitions in Parkinsons and Movement Disorders will give a thorough survey of novel treatments, specialists and blend techniques, just as report on the very most recent discoveries in essential and clinical research.
Parkinsons Congress 2020 Conference reason for existing is to fill your head with the information you can utilize: thoughts, new patterns, and astonishing creativity. Our emphasis is on feasible Development and New Technologies, which we accept are primary to the achievement of individual associations just as our urban communities, states, countries, and world.
Track-1: Parkinsons disease
Parkinsons disease is a dynamic issue that is brought about by degeneration of nerve cells in the part of the cerebrum called the substantia nigra, which controls development. These nerve cells pass on or become weakened, losing the capacity to create a significant chemical called dopamine. Studies have indicated that side effects of Parkinsons create in patients with a 80 percent or more prominent loss of dopamine-delivering cells in the substantia nigra. Levodopa is frequently viewed as the highest quality level of Parkinsons treatment. Levodopa works by intersection the blood-cerebrum barrier, the intricate meshwork of fine veins and cells that filter blood arriving the brain, where it is converted over into dopamine. Bromocriptine, pergolide, pramipexole and ropinirole are prescriptions that copy the job of chemical dispatchers in the cerebrum, making the neurons respond as they would to dopamine.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-2: Movement Disorders
Movement Disorders are a gathering of sensory system conditions that cause anomalous movement, for example fits, yanking or shaking, or, now and again, an absence of movement. Ataxia is a degenerative disorders influencing the brain, brainstem or spinal cord. This can bring about awkwardness, mistake, flimsiness, lopsidedness, tremor or an absence of coordination while performing willful developments. Dystonia results from abnormal working of the basal ganglia, a profound part of the brain which helps control the coordination of movement. These districts of the cerebrum control the speed and ease of movement and avert undesirable movements.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-3: Epidemiology of Parkinsons
Parkinsons disease (PD) is one of the most recognized neurologic disorders, influencing roughly 1% of individuals older than 60 years and causing dynamic disability that can be eased back, yet not stopped, by treatment. The epidemiological highlights have been examined in depth, yet the techniques used to move toward the issues have differed extraordinarily, and the outcomes spread a wide scope of components and are commonly uncertain. The rough predominance pace of PD has been reported for to extend from 15 per 100,000 to 12,500 per 100,000, and the frequency of PD from 15 for every 100,000 to 328 per 100,000, with the disease being less normal in Asian countries. The health-related personal satisfaction of PD patients is connected not exclusively to their motor incapacity, but in addition to their non-motor symptoms of depression, sleeping Disorder, bladder, and sexual dysfunction.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-4: Neuromuscular Disorders
Neuromuscular disease is an expansive term that incorporates numerous ailments and disease that disable the working of the muscles. These may straightforwardly include the muscle legitimately or indirectly involve the nerves or the Neuromuscular junction. The indications of Neuromuscular illnesses may incorporate Numbness, Painful abnormal sensation, muscle weakness, muscle atrophy, muscle agony or jerking. Muscular dystrophy is a group of more than 30 conditions that lead to muscle shortcoming and degeneration. As the condition advances, it gets more diligently to move. At times, it can influence breathing and heart work, prompting perilous inconveniences.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-5: Risk Factors of Parkinson’s Disease
The exact causes aren't completely comprehended, analysts have distinguished attributes that expansion an individual's risk of developing Parkinsons, including sex, age, race, and hereditary factors. In any case, it is significant that by far most of instances of PD are viewed as idiopathic Parkinsons malady. The investigation demonstrated that people with Parkinsons disease were multiple times bound to have a background marked by melanoma. Moreover, individuals with melanoma had multiple times the risk of creating Parkinsons.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-6: Mitochondrial Dysfunction
Mitochondrial dysfunction is the root cause of many diseases that are bewildering in their variety and complexity. They include rare genetic disorders in children, some forms of heart disease, and most likely many cases of Parkinsons disease. Individuals with autism experience difficulty with communication. They experience trouble understanding what other individuals think and feel. This makes it difficult for them to convey what needs be, either with words or through motions, outward appearances, and contact.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-7: Neurosurgery
Neurosurgery is the careful specialization that treats maladies and disorders of the brain and spinal cord. Back pain can some of the time produce neurological manifestations, for example, deadness, muscle shortcoming, and loss of entrail and bladder control because of dysfunction at the nerve root. Stem cell-based medications are rising as the most encouraging methodology for the advancement of a valuable regenerative treatment that could be utilized in an enormous number of patients. In spite of the fact that progress in this field has been moderate, various energizing clinical preliminaries are currently not too far off, and there is a certifiable expectation that stem cells will enter the center in the short-to-medium-term future.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-8: Neuroimaging
Neuroimaging is the order that manages the in vivo delineation of anatomy and capacity of the Central Nervous system (CNS) in wellbeing and disease. Diffusion tensor imaging (DTI) is a promising strategy for portraying microstructural changes or contrasts with neuropathology and treatment. The dissemination tensor might be utilized to describe the extent, anisotropy, and direction of the diffusion tensor.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-9: Free Radicals and Aging in Parkinsons
Free radical production and their focused on activity on biomolecules have roles in maturing and age-related disorders, for example, Parkinsons disease (PD). There is an age-related increment in oxidative harm to the brain, and aging is viewed as a hazard factor for PD. The normal connection among aging and PD at the cellular level with unique reference to oxidative damage brought about by free radicals. Oxidative harm incorporates mitochondrial dysfunction, dopamine auto-oxidation, α-synuclein conglomeration, glial cell enactment, modifications in calcium flagging, and overabundance free iron.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-10: Insights and therapeutics: Parkinsons disease
Mutations in the protein DJ-1 reason autosomal passive types of Parkinsons Disease (PD) and oxidized DJ-1 is found in the brain of idiopathic PD peoples. While a few capacities have been credited to DJ-1, its commitment to PD pathogenesis isn't yet clear. The pertinence of DJ-1 as a PD biomarker is additionally talked about, as are contemplates investigating DJ-1 as a potential remedial objective for PD and neurodegeneration. Monoamine oxidase inhibitors (MAOIs) were the principal sort of stimulant developed. They're successful, however they've by and large been supplanted by antidepressants that are more secure and cause less symptoms.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-11: Clinical Trials in Parkinsonism
Clinical Trials are structured by a severe convention or procedure, guaranteeing that new medicines are tried in a controlled manner to limit any hazard to members. The impact of the treatment is deliberately observed and, notwithstanding deciding their viability, information is gathered on security angles, for example, antagonistic responses and communication with different prescriptions. Here and there a preliminary will contemplate the impacts of utilizing a current treatment in various ways, for example, another plan of the medication.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-12: Parkinson’s disease Complication
Cognitive Problems may encounter psychological issues (dementia) and thinking troubles. These typically happen in the later phases of Parkinsons disease. Such cognitive issues aren't very receptive to medication. Depression and emotional changes may encounter melancholy, at times in the beginning periods. Getting treatment for depression can make it simpler to deal with different difficulties of Parkinsons Disease.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Track-13: Pathophysiology of Parkinsons
Physiologically, the side effects related with Parkinsons disease are the consequence of the loss of numerous neurotransmitters, most strikingly dopamine. The course of the disease is profoundly factor, with certain patients showing not very many side effects as they age and others whose side effects progress quickly. The motor signs of Parkinsons sickness are thought to bring about enormous part from decrease of dopamine in the basal ganglia. In the course of the most recent couple of years, a large number of the practical and anatomical outcomes of dopamine misfortune in these structures have been recognized, both in the basal ganglia and in related territories in thalamus and cortex.
Related Conferences:
9th International Conference on Parkinsons and Movement Disorders, November 16-12, 2020 at Tokyo, Japan | International Congress on Parkinsons and Movement Disorders, September 13, 2020 at PA, USA |Hope 2020 Conference – Physiopathology of Parkinsons Disease, January 29-31, 2020 at Paris, France | World Congress on Parkinsons and Related Disorders, June 07-10, 2020 at Prague, Czech Republic | Advances in Alzheimer’s and Parkinson’s Therapies, April 02-05, 2020 at Vienna, Austria | Redding Parkinsons Support Group-Annual Conference, April 10, 2020 at Anderson, CA.
Related Association and Societies:
International Parkinson and Movement Disorder Society, European Parkinson’s Disease Association, American Parkinson Disease Association, Parkinson’s NSW, UK Parkinson’s Action Network, Danish Movement Disorder Society, American Academy of Neurology, Michael J. Fox Foundation, Movement Disorders Society, Parkinson's Unity Walk, European Neurological Society, National Parkinson Foundation, Austrian Parkinson's Disease Society, Parkinson Society Canada, Parkinson Association of the Carolinas, Movement Disorder Society of Japan.
Parkinson's disease is a progressive nervous system condition characterized by tremor, muscle stiffness, and mild, imprecise movement, which mainly affects the elderly and adults. It is linked to brain basal ganglia degeneration and neurotransmitter dopamine deficiency.
It has been observed that dopamine – producing cells known as dopaminergic neurons in the substantia nigra part of the brain – has died according to neurological studies to date that showed that dopamine a neurotransmitter in the brain gradually lowered its rate and that contributes to Parkinson's disease. The progressive nervous system condition influences the movement of people, such as speaking, writing, walking and other voluntary activities, using various treatments for Parkinson's disease but still raising the death rate of Parkinson's disease.
The condition of Parkinson is a progressive neurological disorder caused by neurodegeneration. Approximately 10 million people worldwide suffer from Parkinson's disease. In 2012, the global prevalence was about 2.18 million cases worldwide where the US market had $1.15 billion. The Parkinson's disease market in the US is expected to rise from $1.1 billion in sales in 2012 to $2.3 billion in 2022 at a rate of 7.3 percent. Treatment market value is expected to rise from $3.6 billion in 2012 to $5.3 billion in 2022. The US- has the largest market share for Parkinson's clinical disease of 44% by 2022, which is rising from 32% in 2012, led by Japan, Brazil and Germany with 13%, 11% and 10%. Approximately 1 million people in the US have Parkinson's disease, 60,000 of which have been diagnosed annually. Around 127,000 people suffer from PD in the United Kingdom. Male has 50% higher risk than females, but 4 to 5% of patient cases are younger than 40 years and it is known as Parkinson's disease Young-onset.
Major Associations around the globe:
National Parkinson Foundation
American Parkinson Disease Association (APDA)
Parkinson’s disease Foundation
Movement Disorder Society of Australia
Parkinson's Unity Walk
Movement Disorder Society of Japan
Moroccan Neurological Society Movement Disorders Group
Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia
Ecuador Movement Disorders Group
Austrian Parkinson's Disease Society
Danish Movement Disorder Society
International Parkinson and Movement Disorder Society
Top universities globally working in the field of Parkinson Disease